The EBITDA for the quarter rose by 24.6 per cent yoy to Rs. 7.45 crore as against Rs.  5.98 crore in the corresponding quarter last year, with a corresponding margin contraction of 6 bps. EBITDA margin for the quarter stood at 6.5 per cent.

The PAT for the quarter came in at Rs. 12.4 crore, yoy increase of 75.6 per cent. Due to strong operating performance and increase in other income aided this PAT growth.

Following stocks are close to their 52-week low as at 1.06 p.m. on October 26, 2018.

The markets on October 26, 2018 opened gap down. BSE Sensex is trading at 33,576.83, down by 113.26 points and the Nifty is trading at 10,094.30, down by 30.60 points. 

The unadjusted net loss for the quarter came in at Rs. 222 crore as against profit Rs. 113.04 crore in the corresponding quarter last year. This was mainly due to impairment loss amounting to Rs. 297.65 crore of investment in associate.

Glenmark Pharmaceuticals Inc., USA has received the final approval from the USFDA for FS topical oil. Shares of the company, however, slipped on Friday morning.

The company’s consolidated order book as on September 30, 2018 stood at Rs. 900 crore which comprised of 74 per cent from domestic orders and 26 per cent international orders.

TVS Motor Company, a leading manufacturer of two-wheelers and three-wheelers, has launched its super premium offering TVS RR 310, the 125cc scooter TVS NTORQ 125 and the race machine TVS RTR 200 4V Race Edition 2.0 at the International motorcycle show, Argentina which is held in Buenos Aires. Through this auto show, the company intends to strengthen its presence in the Argentinian market.

Overall volumes in futures & options currently stand at 2.18 crore contracts with a turnover of Rs. 18,72,794.65 crore.

Overall volumes in futures & options currently stand at 2.18 crore contracts with a turnover of Rs. 18,72,794.65 crore.